Congressmen Ami Bera, David Cicilline, Rodney Davis and Adam Kinzinger talk problem solving.
REPHRASING: A winning strategy to get a seat in Congress? Not mentioning you're in Congress. Words like "Congress," "senator" and "representative" have noticeably been missing from campaign ads this cycle. “When Congress has at best a 20 percent approval rating, it’s pretty hard to run as an incumbent,” No Labels Co-Founder Mark McKinnon says: Rosalind S. Helderman for The Washington Post: Many lawmakers not mentioning word ‘Congress’ in campaign ads
DIVIDE AND SUBTRACT: As the parties grow more polarized, the divide between them has increased and a large number of registered voters have been subtracted from the parties. But, "For better or worse, America is, and for the foreseeable future will remain, a two-party system. Therefore, to make America work for all Americans, we need to make the two party system work -- for the better and not for the worse. The only way that can be done is to restore the middle and to give the center more of a voice in the political process." Ed Crego, George Muñoz and Frank Islam for The Huffington Post: The Politics of Division and Subtraction
EXIT INTERVIEWS: Sens. Olympia Snowe (R-ME) and Kent Conrad (D-ND) and Rep. Gary Ackerman (D-NY) and Geoff Davis (R-KY) are leaving Congress. Why? HINT: it has to do with the current level of gridlock: Josh Tyrangiel for Businessweek: A Congressional Exit Interview
BLAME GAME: The gridlock in Washington has led to finger-pointing between members of Congress and the President. All sides would prefer to shift the responsibility away from themselves rather than find common ground to create solutions. In this blame game, none of us win: Reid Wilson for National Journal: The Powerful, Powerless President
ACTION OF THE DAY: This week, No Budget, No Pay received two new co-sponsors. Click here to write a message on Rep. Tim Scott's (R-SC) Facebook wall and click here to write a comment on one of Rep. Paul Gosar's (R-AZ) Facebook posts thanking them for their support.
STAT OF THE DAY: The House passed an FDA user-fee bill, which will provide the FDA with more than $6 billion over five years, as well as arranging for generic drug companies to pay $300 million per year in exchange for faster agency attention to their products: Brett Norman for POLITICO: House extends FDA user fees